In 2008, the stock market was struck by the great recession. However, stocks have since hit a new all-time high, with numerous companies having successful price-to-earnings ratios.
In fact, most investors are finding it hard to purchase low-price stocks, as most companies are trading at market caps of one billion dollars.
Not only are stocks more expensive, but some are even trading closer to 25 times their annual earnings, which is notable for several reasons.
However, this does not mean that low-price stocks are impossible to find, as there is still a handful of undervalued stocks available for less than a dollar per share.
In the article below, we have compiled a list of the best stocks under $1, which are currently available for purchase and trade.
1.Argonaut Gold
Stock Price: $0.81
Average Trade Volume: 124,789 shares
Consensus Ratings: 2 buy – 1 hold – 0 sell
Consensus Trade Target: $2.63 (224.1% upside)
Argonaut Gold is a company based in Canada, where it promotes mine-based functions such as development, gold mining, and mineral exploration.
The company’s main assets are based in the El Castillo and San Augustin mines, which are both located in Durango, Mexico. Other notable assets include the Lo Colorada mine located in Sonora, Mexico; the Florida Canyon mine located in Nevada, Us; and the Cerro del Gallo mine in the state of Guanajuato, Mexico.
Argonaut Gold was founded in 2007 and currently manages advanced exploration projects such as the San Antonio project in Mexico and Magina project in Canada. The company’s headquarters are based in Reno, where they continue to pursue their passion for mining and underground exploration.
2.Cidara Therapeutics
Stock Price: $0.59
Average Trade Volume: 310,832 shares
Consensus Ratings: 5 buy – 0 hold – 0 sell
Consensus Trade Target: $6.45 (1,002.6% upside)
Cidara Therapeutics is a biotech company that seeks to develop active anti-infectives for the treatment and prevention of fatal diseases.
The company was first launched in the United States, with its most notable product being a molecule called rezafungin acetate.
This molecule comes from the echinocandin class of antifungals and can be used to treat and prevent fungal infections. Cidara also works to combat viral infections such as influenza, HIV, and COVID-19.
During its launch in 2012, the company was known as K2. However, it eventually changed its name to Cidara Therapeutics in 2014. The company’s headquarters are based in San Diego, California.
3.Rigel Pharmaceuticals
Stock Price: $0.70
Average Trade Volume: 2.41 million shares
Consensus Ratings: 2 buy – 4 hold – 0 sell
Consensus Trade Target: $4.20 (499.1% upside)
Rigel Pharmaceuticals is another biotech company that produces molecular drugs to treat various conditions such as cancer and immune diseases.
Out of its many products, the company is best known for Tavalisse, which is an oral spleen tyrosine kinase inhibitor for the treatment of chronic immune thrombocytopenia.
Rigel also develops other pharmaceuticals such as fostamatinib, which can be used to combat anemia, COVID-19, and countless other diseases.
The company was first established in 1996 and has a strategic partnership with Eli Lily. Its headquarters are based in San Francisco, California.
4.Greenlane
Stock Price: $0.30
Average Trade Volume: 1.63 million shares
Consensus Ratings: 6 buy – 0 hold – 0 sell
Consensus Trade Target: $3.22 (972.2% upside)
Greenlane Holdings is a cannabis company that develops safe, child-resistant products such as accessories, vape solutions, and home products.
The company operates through two sections: consumer goods and industrial goods. It also distributes its products across the United States, Canada, and Europe.
Some of its most notable products include consumption accessories, vaporizers, rolling papers, apparel lines, grinders, and merchandise.
Greenlane also sells products through e-commerce websites such as Vapor.com, Vapor.ca, and Aerospaced. The company was founded in 2005 and is headquartered in Boca Raton, Florida.
5.Tullow Oil
Stock Price: $0.31
Average Trade Volume: 108,189 shares
Consensus Ratings: 3 buy – 1 hold – 0 sell
Consensus Trade Target: $2.29 (163.6% upside)
Tullow Oil is an oil company that specializes in oil and gas exploration, with the company owning productions across Africa and South America.
Because of this, the company has developed a notable portfolio, which now includes a total of 30 licenses in 8 countries with 30 active wells. Tullow was founded by Aidan Heavey and holds a current revenue of 1.273 billion US dollars.
Despite all of this, Tullow Oil is actually a British company and has been headquartered in London since its founding in 1985.
6.Clarus Therapeutics
Stock Price: $0.42
Average Trade Volume: 8.24 million shares
Consensus Ratings: 4 buy – 0 hold – 0 sell
Consensus Trade Target: $7.90 (1,775.1% upside)
Clarus Therapeutics is a pharmaceutical company based in the US, where it develops oral testosterone replacement therapy for male patients.
Beyond its alternative treatments, the company also produces a substance called Jatenzo, which takes the form of an oral formulation of testosterone undecanoate.
This substance can be used to treat men with hormonal disorders such as hypogonadism. Clarus is also known to develop treatments for breast cancer and CoQ10 deficiencies, with the company holding a license agreement with McGill University.
Claris Therapeutics was first founded in 2003 and is currently based in Northbrook, Illinois where it continues to develop treatments.
7.IMV
Stock Price: $0.87
Average Trade Volume: 108,189 shares
Consensus Rates: 3 buy – 1 hold – 0 sell
Consensus Trade Target: $2.29 (163.6% upside)
IMV is an oncology company that develops clinical-stage therapies for the treatment of both solid and hematological cancers.
Among its various therapies, IMV is notable for its lead drug candidate maveropepimut-S, which is a DPX-based treatment used to combat harmful cells and prevent conditions such as ovarian cancer and microsatellite tumors.
IMV also develops treatments for lymphoma, COVID-19, and a range of infectious diseases.
The company is based in Dartmouth, Canada, and was formerly known as Immunovaccine until it changed its name to IMV in 2018.
8.Applied Genetic Technologies
Stock Price: $0.95
Average Trade Volume: 378,181 shares
Consensus Rates: 7 buy – 0 hold – 0 sell
Consensus Trade Target: $15.00 (1,478.9% upside)
AGT is a clinical-stage biotech company that develops transformative genetic therapies for patients with rare and debilitating diseases.
The biotech company is notable for its advanced products, which include ophthalmology development programs such as x-linked retinitis pigmentosa and achromatopsia.
Both of these products are in clinical trials and can be used to treat various rare diseases. AGT also develops treatments for central nervous system disorders such as frontotemporal dementia and amyotrophic lateral sclerosis.
AGT was founded in 1996 and is headquartered in Alachua, Florida. The company is also in collaboration with the local university and companies such as Bionic Sight.
9.Eloxx Pharmaceuticals
Stock Price: $0.31
Average Trade Volume: 218,887 shares
Consensus Rates: 3 buy – 1 hold – 0 sell
Consensus Trade Target: $2.52 (712.9% upside)
Eloxx Pharmaceuticals is a biopharmaceutical company that develops modulations for the treatment of rare and ultra-rare codon diseases.
The company’s lead product is a drug called ELX-02, which is currently in phase 2 of clinical trials. Eloxx developed this solution to treat cystic fibrosis and nephropathic cystinosis with diagnosed mutations.
The company also develops treatment programs for conditions such as alport syndrome and recessive dystrophic bullosa.
Eloxx Pharmaceuticals was launched in 2013 and is headquartered in Watertown. Massachusetts, where it continues to develop treatments.
10.Gold Standard Ventures
Stock Price: $0.42
Average Trade Volume: 588,834 shares
Consensus Rate: 3 buy – 0 hold – 0 sell
Consensus Trade Target: $1.20 (185.6% upside)
Gold Standard Ventures is an exploration company that works in the development of mining and district-scale.
The company searches for gold and other mineral resources in Nevada, where it remains in control of the Railroad-Pinion project, which covers an area of approximately 53,570 acres across Elko County.
The company was founded in 2004 and is located in Vancouver, Canada. However, its main development is still based in Nevada.
11.China Overseas Property
Stock Price: $0.90
Average Trade Volume: 1,914 shares
Consensus Rates: 3 buy – 1 hold – 0 sell
Consensus Trade Target: N/A
China Overseas Property is an investment holding company (see also ‘What Is An Investment Holding Company?’) that offers land management services in Hong Kong, Macau, and the People’s Republic of China.
The company mainly operates through land management services, value-added services, and car parking business segments.
These different operations provide vital services such as cleaning, security, and general maintenance. Some even allow potential investors to trade in car spaces and other provisions.
During its initial launch, the company was known as China Overseas Management Services, but the company changed its name in 2015. China Overseas was first established in 1985 and is based in Hong Kong.
12.Unity Biotechnology
Stock Price: $0.70
Average Trade Volume: 712,322 shares
Consensus Rates: 4 buy – 0 hold – 0 sell
Consensus Trade Target: $6.40 (814.3% upside)
Unity Biotechnology is a biotech company that develops therapeutics for the side effects and diseases of old age.
Among the company’s various treatments, it is most notable for its drug candidate UBX1325, which is in phase 2 of clinical trials and can be used to treat age-related eye diseases such as macular degeneration and diabetic retinopathy.
The company also produces other drugs such as UBX1967, UBX2050, and UBX2089, which can be used to treat neurological and macular diseases.
The company was launched in 2009 and was once called Forge Inc. However, it would later change its name in 2015. Unity Biotechnology is based in the US and is headquartered in South San Francisco, California.
13.Cybin
Stock Price: $0.69
Average Trade Volume: 756,923 shares
Consensus Rates: 4 buy – 1 hold – 0 sell
Consensus Trade Target: $9.31 (1,249.6% upside)
Cybin is a biopharmaceutical company based in Canada, where it develops psychedelic and alternative treatments for various mental disorders.
Through its research, the company was able to develop a prime candidate called CYB003, which is a deuterated psilocybin analog used to treat severe depression and alcoholism.
The company has also developed other treatments such as CYB004 and CYB005, which can be used to treat anxiety and neuroinflammation respectively.
Beyond this, Cybin is also notable for its development of Embark, which is a psychedelic treatment. The bio company was first founded in 2019 and is currently headquartered in Toronto, Canada.
14.Infinity Pharmaceuticals
Stock Price: $0.82
Average Trade Volume: 876,368 shares
Consensus Rates: 6 buy – 0 hold – 0 sell
Consensus Trade Target: $6.83 (730.4% upside)
Infinity Pharmaceuticals is a biopharmaceutical company that produces medicines for those with cancer.
Out of its many products, the company is most notable for IPI-549, which is an oral medicine that inhibits the enzyme phosphoinositide-3-kinase-gamma and can be used in the treatment of breast cancer.
Since its launch, the company has also developed strategic relationships with Intellikine and Verastem. These alliances allow the company to research, produce, and commercialize its treatments.
Infinity Pharmaceuticals was first incorporated in 1995 and has since developed into a point of interest among investors. The company is based in Cambridge, Massachusetts, where its headquarters are still located.
15.UpHealth
Stock Price: $0.79
Average Trade Volume: 118,563 shares
Consensus Rate: 4 buy – 1 hold – 0 sell
Consensus Trade Target: $5.50 (595.2% upside)
UpHealth presents itself as a digital health services company, which means it offers digital patient-centric health services and care.
The company provides various solutions and services, with the most prominent including its Syntranet Core Platform and MedQuest Pharmacy, which offer integrated care management and full-service retail respectively. UpHealth also offers licensed pharmacy services and prescribed medications.
UpHealth was first established in 2019 and is currently headquartered in Delray Beach in California.
16.CubicFarm Systems
Stock Price: $0.39
Average Trade Volume: 11,250 shares
Consensus Rate: 5 buy – 0 hold – 0 sell
Consensus Trade Target: $1.40 (259.0% upside)
CubicFarm Systems is a company that develops, manufactures, and sells cubic farming systems across the world.
The main draw of this company is its CubicFarm System and CubicFarm HydroGreen Grow System, which allows farmers to grow useful products such as lettuce, basil, microgreens, and animal feed.
The company was once called Forty Food Farms. However, it would change its name in 2016 following its launch the previous year. CubicFarm Systems can now be located in Langley, Canada.
17.Skylight Health Group
Stock Price: $0.79
Average Trade Volume: 118,563 shares
Consensus Rate: 4 buy – 1 hold – 0 sell
Consensus Trade Target: $5.50 (595.2% upside)
Skylight Health Group is a healthcare and technology company based in the United States, Colombia, Canada, and the United Kingdom.
The company operates through the US-based multi-state primary healthcare network, which offers various services from primary care to allied health and laboratory testing.
SLHG also owns and operates its own electronic health record, which supports and monitors patients with telemedicine and other alternative methods.
Skylight Health Group was formerly known as CB2 Insights, but the name was later changed in 2020. The actual company was founded in 2014 and is based in the city of Mississauga, Canada.
18.Petrofac
Stock Price: $0.95
Average Trade Volume: 4,692 shares
Consensus Rate: 6 buy – 1 hold – 0 sell
Consensus Trade Target: $160.00 (16,742.1% upside)
Petrofac is a company that designs and manages the infrastructure of energy industries across the world, with notable countries including the United Kingdom, Thailand, Oman, Iraq, Kuwait, the Netherlands, and the United Arab Emirates.
The company operates across three segments, which include engineering and construction, asset solutions, and integrated services. These provide the company with both onshore and offshore engineering, feasibility, and flexible models for clients.
Petrofac was first established in 1981 and is based in St Helier, Jersey, where it continues to operate to this day.
19.Aptinyx
Stock Price: $0.42
Average Trade Volume: 356,881 shares
Consensus Rate: 5 buy – 1 hold – 0 sell
Consensus Trade Target: $4.67 (1,008.5% upside)
This clinical-stage biopharmaceutical company is known for its development of synthetic molecules for the treatment of brain and nervous system disorders.
Since its foundation, the company has sought to revolutionize the pharmaceutical world, as it remains most notable for developing NYX-2925.
This treatment is in the second phase of its clinical development and can be used to treat diabetic peripheral neuropathy, as well as fibromyalgia.
The company was founded in 2015 and is headquartered in Evanston, Illinois. It even has a research collaboration with Allegran.
Final Thoughts
While there are other stocks available for less than $1 per share, the stocks mentioned above remain some of the most viable, as each company offers something different in terms of the market.
Because of this, some of these companies could be considered solid investing ideas, as they are too small to be considered a risk and can attract more interest as the market continues to change.
If you enjoyed this article, you might enjoy our post on ‘Penny Stock Calculator‘.
That is why I made my site - Stock Maven. Now that I feel settled and confident about trading, I want to be a source of help to anyone else who might be struggling to break into the crypto market successfully.
My website is full of my tips and tricks, as well as information that I have always found interesting about crypto. My friends and family are sick of hearing me talk about it, so now it’s your turn!
I hope that you stick around and find something useful on my site. Remember, to make it big in crypto, you’ve got to be confident! Go for it and don’t look back.
- Breaking the Cycle: Understanding Why We Repeat Poor Financial Decision-Making - November 18, 2024
- Unlocking the Potential: Is Silver Investment Worth It? - November 16, 2024
- Emotions and Financial Success: Master Your Way to Wealth - November 15, 2024